BOSTON SCIENTIFIC CORPORATION Equity Securities without Readily Determinable Fair Value, Amount
BOSTON SCIENTIFIC CORPORATION (BSX) had Equity Securities without Readily Determinable Fair Value, Amount of $938.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Investments
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2026-08-03
- 2026-06-30: Equity Securities without Readily Determinable Fair Value, Amount $938.00M.
- 2026-03-31: Equity Securities without Readily Determinable Fair Value, Amount $396.00M.
- 2025-12-31: Equity Securities without Readily Determinable Fair Value, Amount $286.00M.
- 2025-09-30: Equity Securities without Readily Determinable Fair Value, Amount $310.00M.
| Period end | Equity Securities without Readily Determinable Fair Value, Amount | Equity Securities without Readily Determinable Fair Value, Amount as first filed |
|---|---|---|
| 2026-06-30 | $938.00M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $396.00M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $286.00M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $310.00M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $292.00M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $297.00M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $277.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $276.00M 10-Q · filed 2024-11-01 | |
| 2024-06-30 | $243.00M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $218.00M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $194.00M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $207.00M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $215.00M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $219.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $219.00M 10-K · filed 2024-02-20 | $216.00M 10-K · filed 2023-02-23 |
| 2022-09-30 | $171.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $159.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $165.00M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $142.00M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $164.00M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $175.00M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $182.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $183.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $196.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $200.00M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $181.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $171.00M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $173.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $169.00M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $112.00M 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $94.00M 10-Q · filed 2019-11-05 | |
| 2018-09-30 | $73.00M 10-Q · filed 2018-10-29 | |
| 2017-12-31 | $81.00M 10-Q · filed 2018-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |